Robustness of FTIR-Based Ultrarapid COVID-19 Diagnosis Using PLS-DA.

ABSTRACT: The World Health Organization (WHO) declared the Omicron variant (B.1.1.529) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the Coronavirus disease 2019 (COVID-19) pandemic, as a variant of concern on 26 November 2021. By this time, 42% of the world's population had received at least one dose of the vaccine against COVID-19. As on 1 October 2022, only 68% of the world population got the first dose of the vaccine. Although the vaccination is incredibly protective against severe complications of the disease and death, the highly contagious Omicron variant, compared to the Delta variant (B.1.617.2), has led the whole world into more chaotic situations. Furthermore, the virus has a high mutation rate, and hence, the possibility of a new variant of

SUBMITTER: Pushpa SR 

PROVIDER: S-EPMC9773962 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature